Where does Cara Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cara Therapeutics, Inc. ranks #24,057 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cara Therapeutics, Inc. hold?

Cara Therapeutics, Inc. holds 11 US utility patents granted between 2015 and 2024, spanning 3 technology areas.

What is Cara Therapeutics, Inc.'s Innovation Score?

Cara Therapeutics, Inc. has an Innovation Score of 31.0 out of 100 (top 64% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cara Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Cara Therapeutics, Inc.'s recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cara Therapeutics, Inc.'s patents?

Cara Therapeutics, Inc.'s patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cara Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cara Therapeutics, Inc.

Q: What technology areas does Cara Therapeutics, Inc. focus on?

Cara Therapeutics, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 11 patents. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cara ranks #24,057 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.

#24,057
of 50,000 US assignees by volume: Top 64%
by Innovation Score (31.0/100): 19.8
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24057 · US Corporation #24,057 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,057/50,000
PHOTO-FINISH Cambridge Sound Mana…
CPC-NARROW A61K · 3 areas
INNOV-THIN 31.0/100
CLAIMS-RICH 19.8 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cambridge Sound Management, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cara Therapeutics · this assignee

31
3D Lighting Innovati… · lowest

7

What this shows Cara's Innovation Score is 31.0/100 (top 64% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Cara's grants concentrate

Cara Therapeutics, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2015. By volume, Cara sits between Cambridge Sound Management, Inc. and Cardomon International Limited.

Cara's three-year grant acceleration

Cara Therapeutics, Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cambridge Sound M…

11
Canadian National…

11
Cansonic

11
Capat

11
Carbitex

11
Carbodeon Oy

11
Carbon Sink

11
Cardomon Internat…

11
Cara Therapeutics ◀

11

What this shows Cara holds 11 patents at rank #24,112, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cara

By rank, the assignees closest to #24,112 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Cara's primary technology class.

Cara's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 Top 64% higher than 36% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cara Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2016	3	27.3%
2018	2	18.2%
2020	1	9.1%
2021	2	18.2%
2023	1	9.1%
2024	1	9.1%

Which technologies does Cara Therapeutics, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 11

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 8

C07K - PEPTIDES 8

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#24,057

of 50,000 tracked assignees

Innovation Score

31.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.